IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CASS K NAKASONE

Allopathic & Osteopathic Physicians Orthopaedic Surgery

NPI
1316011091
CMS profile
798572
Location
HONOLULU, HI

General Payments · PY2018–2024

$1,000,363.52

  • Reported across 367 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$127,686.66

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Orthopaedic Surgery HI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Royalty or License $93,440.30 26
Consulting Fee $31,835.00 8
Food and Beverage $1,958.15 16
Travel and Lodging $453.21 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ORTHO DEVELOPMENT CORPORATION $119,083.23 37
ENCORE MEDICAL, LP $4,585.00 2
ORTHALIGN INC $3,653.05 9
Next Science LLC $245.45 1
Kinamed, Inc. $70.43 1
Pacira Pharmaceuticals Incorporated $49.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $182,374.05 71
PY2019 $127,488.23 42
PY2020 $159,924.41 30
PY2021 $114,465.57 57
PY2022 $149,221.22 57
PY2023 $139,203.38 59
PY2024 $127,686.66 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ENCORE MEDICAL, LP $2,620.00 05/01/2024 Consulting Fee Undisputed 01/23/2026 1154727983 CMS
ENCORE MEDICAL, LP $1,965.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1154727991 CMS
Kinamed, Inc. $70.43 11/21/2024 Food and Beverage Undisputed 01/23/2026 1093027444 CMS
Next Science LLC $245.45 05/23/2024 Food and Beverage Undisputed 01/23/2026 1147392530 CMS
ORTHALIGN INC $20.00 02/03/2024 Food and Beverage Undisputed 01/23/2026 1126500782 CMS
ORTHALIGN INC $40.00 02/03/2024 Food and Beverage Undisputed 01/23/2026 1126500784 CMS
ORTHALIGN INC $2,000.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1126501356 CMS
ORTHALIGN INC $250.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1126501358 CMS
ORTHALIGN INC $6.95 08/20/2024 Food and Beverage Undisputed 01/23/2026 1126500786 CMS
ORTHALIGN INC $500.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1126501360 CMS
ORTHALIGN INC $187.07 10/02/2024 Food and Beverage Undisputed 01/23/2026 1126500788 CMS
ORTHALIGN INC $500.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 1126501362 CMS
ORTHALIGN INC $149.03 12/17/2024 Food and Beverage Undisputed 01/23/2026 1126500790 CMS
ORTHO DEVELOPMENT CORPORATION $2,840.81 01/15/2024 Royalty or License Undisputed 01/23/2026 1154966066 CMS
ORTHO DEVELOPMENT CORPORATION $3,222.80 01/15/2024 Royalty or License Undisputed 01/23/2026 1154966110 CMS
ORTHO DEVELOPMENT CORPORATION $60.26 02/12/2024 Food and Beverage Undisputed 01/23/2026 1154966126 CMS
ORTHO DEVELOPMENT CORPORATION $4,526.55 02/15/2024 Royalty or License Undisputed 01/23/2026 1154966068 CMS
ORTHO DEVELOPMENT CORPORATION $3,688.40 02/15/2024 Royalty or License Undisputed 01/23/2026 1154966112 CMS
ORTHO DEVELOPMENT CORPORATION $4,327.02 03/15/2024 Royalty or License Undisputed 01/23/2026 1154966070 CMS
ORTHO DEVELOPMENT CORPORATION $3,271.68 03/15/2024 Royalty or License Undisputed 01/23/2026 1154966114 CMS
ORTHO DEVELOPMENT CORPORATION $4,122.48 04/15/2024 Royalty or License Undisputed 01/23/2026 1154966072 CMS
ORTHO DEVELOPMENT CORPORATION $3,856.95 04/15/2024 Royalty or License Undisputed 01/23/2026 1154966116 CMS
ORTHO DEVELOPMENT CORPORATION $5,199.35 05/15/2024 Royalty or License Undisputed 01/23/2026 1154966074 CMS
ORTHO DEVELOPMENT CORPORATION $2,679.00 05/15/2024 Royalty or License Undisputed 01/23/2026 1154966118 CMS
ORTHO DEVELOPMENT CORPORATION $211.31 05/22/2024 Food and Beverage Undisputed 01/23/2026 1154966120 CMS
ORTHO DEVELOPMENT CORPORATION $2,304.38 06/15/2024 Royalty or License Undisputed 01/23/2026 1154966088 CMS
ORTHO DEVELOPMENT CORPORATION $2,258.40 06/15/2024 Royalty or License Undisputed 01/23/2026 1154966104 CMS
ORTHO DEVELOPMENT CORPORATION $2,688.45 06/15/2024 Royalty or License Undisputed 01/23/2026 1154966106 CMS
ORTHO DEVELOPMENT CORPORATION $982.00 06/15/2024 Royalty or License Undisputed 01/23/2026 1154966108 CMS
ORTHO DEVELOPMENT CORPORATION $194.40 07/10/2024 Food and Beverage Undisputed 01/23/2026 1154966128 CMS
ORTHO DEVELOPMENT CORPORATION $3,747.34 07/15/2024 Royalty or License Undisputed 01/23/2026 1154966086 CMS
ORTHO DEVELOPMENT CORPORATION $4,145.00 07/15/2024 Royalty or License Undisputed 01/23/2026 1154966102 CMS
ORTHO DEVELOPMENT CORPORATION $3,490.24 08/15/2024 Royalty or License Undisputed 01/23/2026 1154966084 CMS
ORTHO DEVELOPMENT CORPORATION $3,346.00 08/15/2024 Royalty or License Undisputed 01/23/2026 1154966100 CMS
ORTHO DEVELOPMENT CORPORATION $18,000.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1154966138 CMS
ORTHO DEVELOPMENT CORPORATION $4,749.28 09/13/2024 Royalty or License Undisputed 01/23/2026 1154966082 CMS
ORTHO DEVELOPMENT CORPORATION $3,398.20 09/13/2024 Royalty or License Undisputed 01/23/2026 1154966098 CMS
ORTHO DEVELOPMENT CORPORATION $26.77 09/27/2024 Food and Beverage Undisputed 01/23/2026 1154966130 CMS
ORTHO DEVELOPMENT CORPORATION $116.10 09/27/2024 Food and Beverage Undisputed 01/23/2026 1154966132 CMS
ORTHO DEVELOPMENT CORPORATION $453.21 09/30/2024 Travel and Lodging Undisputed 01/23/2026 1154966134 CMS
ORTHO DEVELOPMENT CORPORATION $6,000.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 1154966096 CMS
ORTHO DEVELOPMENT CORPORATION $4,007.81 10/15/2024 Royalty or License Undisputed 01/23/2026 1154966080 CMS
ORTHO DEVELOPMENT CORPORATION $5,468.20 10/15/2024 Royalty or License Undisputed 01/23/2026 1154966094 CMS
ORTHO DEVELOPMENT CORPORATION $160.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 1154966122 CMS
ORTHO DEVELOPMENT CORPORATION $284.61 10/29/2024 Food and Beverage Undisputed 01/23/2026 1154966124 CMS
ORTHO DEVELOPMENT CORPORATION $3,053.55 11/15/2024 Royalty or License Undisputed 01/23/2026 1154966078 CMS
ORTHO DEVELOPMENT CORPORATION $3,597.80 11/15/2024 Royalty or License Undisputed 01/23/2026 1154966092 CMS
ORTHO DEVELOPMENT CORPORATION $136.06 11/25/2024 Food and Beverage Undisputed 01/23/2026 1154966136 CMS
ORTHO DEVELOPMENT CORPORATION $5,037.41 12/12/2024 Royalty or License Undisputed 01/23/2026 1154966076 CMS
ORTHO DEVELOPMENT CORPORATION $3,431.20 12/12/2024 Royalty or License Undisputed 01/23/2026 1154966090 CMS
Pacira Pharmaceuticals Incorporated $49.50 10/02/2024 Food and Beverage Undisputed 01/23/2026 1151241213 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.